Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

Conclusions
Sofosbuvir plus ribavirin combination was associated with a high rate of complete clinical response and a low rate of serious adverse events in HCV-cryoglobulinaemia vasculitis.

Source: Annals of the Rheumatic Diseases - September 8, 2016 Category: Rheumatology Authors: Saadoun, D., Thibault, V., Si Ahmed, S. N., Alric, L., Mallet, M., Guillaud, C., Izzedine, H., Plaisier, A., Fontaine, H., Costopoulos, M., Le Garff-Tavernier, M., Hezode, C., Pol, S., Musset, L., Poynard, T., Cacoub, P. Tags: Travel medicine, Pain (neurology), Renal medicine, Degenerative joint disease, Musculoskeletal syndromes, Vascularitis Clinical and epidemiological research Source Type: research